Industry Research Reports

Home > Reports > Chemical & Material > Cefuroxime Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Cefuroxime Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-24

Pages: 106 Pages

Report ld: 4211236

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Cefuroxime Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Cefuroxime Sodium was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cefuroxime Sodium was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cefuroxime Sodium was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Cefuroxime Sodium include NecLife, Sinopharm, Yongning Pharma, Titan Pharmaceutical, ACS Dobfar, Guobang Pharma, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Cefuroxime Sodium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cefuroxime Sodium by region & country, by Type, and by Application.

The Cefuroxime Sodium market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cefuroxime Sodium.

MARKET SEGMENTATION

By Company

NecLife
Sinopharm
Yongning Pharma
Titan Pharmaceutical
ACS Dobfar
Guobang Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

≥ 96.0%
＜ 96.0%

Segment by Application

Respiratory Infections
ENT Infections
Urinary Tract Infection
Meningitis
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cefuroxime Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Cefuroxime Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Cefuroxime Sodium in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Cefuroxime Sodium Product Introduction

1.2 Global Cefuroxime Sodium Market Size Forecast

1.2.1 Global Cefuroxime Sodium Sales Value (2020-2031)

1.2.2 Global Cefuroxime Sodium Sales Volume (2020-2031)

1.2.3 Global Cefuroxime Sodium Sales Price (2020-2031)

1.3 Cefuroxime Sodium Market Trends & Drivers

1.3.1 Cefuroxime Sodium Industry Trends

1.3.2 Cefuroxime Sodium Market Drivers & Opportunity

1.3.3 Cefuroxime Sodium Market Challenges

1.3.4 Cefuroxime Sodium Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Cefuroxime Sodium Players Revenue Ranking (2024)

2.2 Global Cefuroxime Sodium Revenue by Company (2020-2025)

2.3 Global Cefuroxime Sodium Players Sales Volume Ranking (2024)

2.4 Global Cefuroxime Sodium Sales Volume by Company Players (2020-2025)

2.5 Global Cefuroxime Sodium Average Price by Company (2020-2025)

2.6 Key Manufacturers Cefuroxime Sodium Manufacturing Base and Headquarters

2.7 Key Manufacturers Cefuroxime Sodium Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Cefuroxime Sodium

2.9 Cefuroxime Sodium Market Competitive Analysis

2.9.1 Cefuroxime Sodium Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Cefuroxime Sodium Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefuroxime Sodium as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 ≥ 96.0%

3.1.2 ＜ 96.0%

3.2 Global Cefuroxime Sodium Sales Value by Type

3.2.1 Global Cefuroxime Sodium Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Cefuroxime Sodium Sales Value, by Type (2020-2031)

3.2.3 Global Cefuroxime Sodium Sales Value, by Type (%) (2020-2031)

3.3 Global Cefuroxime Sodium Sales Volume by Type

3.3.1 Global Cefuroxime Sodium Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Cefuroxime Sodium Sales Volume, by Type (2020-2031)

3.3.3 Global Cefuroxime Sodium Sales Volume, by Type (%) (2020-2031)

3.4 Global Cefuroxime Sodium Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Respiratory Infections

4.1.2 ENT Infections

4.1.3 Urinary Tract Infection

4.1.4 Meningitis

4.1.5 Other

4.2 Global Cefuroxime Sodium Sales Value by Application

4.2.1 Global Cefuroxime Sodium Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Cefuroxime Sodium Sales Value, by Application (2020-2031)

4.2.3 Global Cefuroxime Sodium Sales Value, by Application (%) (2020-2031)

4.3 Global Cefuroxime Sodium Sales Volume by Application

4.3.1 Global Cefuroxime Sodium Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Cefuroxime Sodium Sales Volume, by Application (2020-2031)

4.3.3 Global Cefuroxime Sodium Sales Volume, by Application (%) (2020-2031)

4.4 Global Cefuroxime Sodium Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Cefuroxime Sodium Sales Value by Region

5.1.1 Global Cefuroxime Sodium Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Cefuroxime Sodium Sales Value by Region (2020-2025)

5.1.3 Global Cefuroxime Sodium Sales Value by Region (2026-2031)

5.1.4 Global Cefuroxime Sodium Sales Value by Region (%), (2020-2031)

5.2 Global Cefuroxime Sodium Sales Volume by Region

5.2.1 Global Cefuroxime Sodium Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Cefuroxime Sodium Sales Volume by Region (2020-2025)

5.2.3 Global Cefuroxime Sodium Sales Volume by Region (2026-2031)

5.2.4 Global Cefuroxime Sodium Sales Volume by Region (%), (2020-2031)

5.3 Global Cefuroxime Sodium Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Cefuroxime Sodium Sales Value, 2020-2031

5.4.2 North America Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Cefuroxime Sodium Sales Value, 2020-2031

5.5.2 Europe Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Cefuroxime Sodium Sales Value, 2020-2031

5.6.2 Asia Pacific Cefuroxime Sodium Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Cefuroxime Sodium Sales Value, 2020-2031

5.7.2 South America Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Cefuroxime Sodium Sales Value, 2020-2031

5.8.2 Middle East & Africa Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Cefuroxime Sodium Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Cefuroxime Sodium Sales Value

6.2.1 Key Countries/Regions Cefuroxime Sodium Sales Value, 2020-2031

6.2.2 Key Countries/Regions Cefuroxime Sodium Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Cefuroxime Sodium Sales Value, 2020-2031

6.3.2 United States Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Cefuroxime Sodium Sales Value, 2020-2031

6.4.2 Europe Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Cefuroxime Sodium Sales Value, 2020-2031

6.5.2 China Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.5.3 China Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Cefuroxime Sodium Sales Value, 2020-2031

6.6.2 Japan Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Cefuroxime Sodium Sales Value, 2020-2031

6.7.2 South Korea Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Cefuroxime Sodium Sales Value, 2020-2031

6.8.2 Southeast Asia Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Cefuroxime Sodium Sales Value, 2020-2031

6.9.2 India Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

6.9.3 India Cefuroxime Sodium Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 NecLife

7.1.1 NecLife Company Information

7.1.2 NecLife Introduction and Business Overview

7.1.3 NecLife Cefuroxime Sodium Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 NecLife Cefuroxime Sodium Product Offerings

7.1.5 NecLife Recent Development

7.2 Sinopharm

7.2.1 Sinopharm Company Information

7.2.2 Sinopharm Introduction and Business Overview

7.2.3 Sinopharm Cefuroxime Sodium Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Sinopharm Cefuroxime Sodium Product Offerings

7.2.5 Sinopharm Recent Development

7.3 Yongning Pharma

7.3.1 Yongning Pharma Company Information

7.3.2 Yongning Pharma Introduction and Business Overview

7.3.3 Yongning Pharma Cefuroxime Sodium Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Yongning Pharma Cefuroxime Sodium Product Offerings

7.3.5 Yongning Pharma Recent Development

7.4 Titan Pharmaceutical

7.4.1 Titan Pharmaceutical Company Information

7.4.2 Titan Pharmaceutical Introduction and Business Overview

7.4.3 Titan Pharmaceutical Cefuroxime Sodium Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Titan Pharmaceutical Cefuroxime Sodium Product Offerings

7.4.5 Titan Pharmaceutical Recent Development

7.5 ACS Dobfar

7.5.1 ACS Dobfar Company Information

7.5.2 ACS Dobfar Introduction and Business Overview

7.5.3 ACS Dobfar Cefuroxime Sodium Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 ACS Dobfar Cefuroxime Sodium Product Offerings

7.5.5 ACS Dobfar Recent Development

7.6 Guobang Pharma

7.6.1 Guobang Pharma Company Information

7.6.2 Guobang Pharma Introduction and Business Overview

7.6.3 Guobang Pharma Cefuroxime Sodium Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Guobang Pharma Cefuroxime Sodium Product Offerings

7.6.5 Guobang Pharma Recent Development

8 Industry Chain Analysis

8.1 Cefuroxime Sodium Industrial Chain

8.2 Cefuroxime Sodium Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Cefuroxime Sodium Sales Model

8.5.2 Sales Channel

8.5.3 Cefuroxime Sodium Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Cefuroxime Sodium Market Trends

Table 2. Cefuroxime Sodium Market Drivers & Opportunity

Table 3. Cefuroxime Sodium Market Challenges

Table 4. Cefuroxime Sodium Market Restraints

Table 5. Global Cefuroxime Sodium Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Cefuroxime Sodium Revenue Market Share by Company (2020-2025)

Table 7. Global Cefuroxime Sodium Sales Volume by Company (2020-2025) & (MT)

Table 8. Global Cefuroxime Sodium Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Cefuroxime Sodium Price by Company (2020-2025) & (USD/Kg)

Table 10. Key Manufacturers Cefuroxime Sodium Manufacturing Base and Headquarters

Table 11. Key Manufacturers Cefuroxime Sodium Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Cefuroxime Sodium

Table 13. Global Cefuroxime Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefuroxime Sodium as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Cefuroxime Sodium Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Cefuroxime Sodium Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Cefuroxime Sodium Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Cefuroxime Sodium Sales Market Share in Value by Type (2020-2025)

Table 20. Global Cefuroxime Sodium Sales Market Share in Value by Type (2026-2031)

Table 21. Global Cefuroxime Sodium Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)

Table 22. Global Cefuroxime Sodium Sales Volume by Type (2020-2025) & (MT)

Table 23. Global Cefuroxime Sodium Sales Volume by Type (2026-2031) & (MT)

Table 24. Global Cefuroxime Sodium Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Cefuroxime Sodium Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Cefuroxime Sodium Price by Type (2020-2025) & (USD/Kg)

Table 27. Global Cefuroxime Sodium Price by Type (2026-2031) & (USD/Kg)

Table 28. Global Cefuroxime Sodium Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Cefuroxime Sodium Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Cefuroxime Sodium Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Cefuroxime Sodium Sales Market Share in Value by Application (2020-2025)

Table 32. Global Cefuroxime Sodium Sales Market Share in Value by Application (2026-2031)

Table 33. Global Cefuroxime Sodium Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)

Table 34. Global Cefuroxime Sodium Sales Volume by Application (2020-2025) & (MT)

Table 35. Global Cefuroxime Sodium Sales Volume by Application (2026-2031) & (MT)

Table 36. Global Cefuroxime Sodium Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Cefuroxime Sodium Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Cefuroxime Sodium Price by Application (2020-2025) & (USD/Kg)

Table 39. Global Cefuroxime Sodium Price by Application (2026-2031) & (USD/Kg)

Table 40. Global Cefuroxime Sodium Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Cefuroxime Sodium Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Cefuroxime Sodium Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Cefuroxime Sodium Sales Value by Region (2020-2025) & (%)

Table 44. Global Cefuroxime Sodium Sales Value by Region (2026-2031) & (%)

Table 45. Global Cefuroxime Sodium Sales Volume by Region (MT): 2020 VS 2024 VS 2031

Table 46. Global Cefuroxime Sodium Sales Volume by Region (2020-2025) & (MT)

Table 47. Global Cefuroxime Sodium Sales Volume by Region (2026-2031) & (MT)

Table 48. Global Cefuroxime Sodium Sales Volume by Region (2020-2025) & (%)

Table 49. Global Cefuroxime Sodium Sales Volume by Region (2026-2031) & (%)

Table 50. Global Cefuroxime Sodium Average Price by Region (2020-2025) & (USD/Kg)

Table 51. Global Cefuroxime Sodium Average Price by Region (2026-2031) & (USD/Kg)

Table 52. Key Countries/Regions Cefuroxime Sodium Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Cefuroxime Sodium Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Cefuroxime Sodium Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Cefuroxime Sodium Sales Volume, (2020-2025) & (MT)

Table 56. Key Countries/Regions Cefuroxime Sodium Sales Volume, (2026-2031) & (MT)

Table 57. NecLife Company Information

Table 58. NecLife Introduction and Business Overview

Table 59. NecLife Cefuroxime Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 60. NecLife Cefuroxime Sodium Product Offerings

Table 61. NecLife Recent Development

Table 62. Sinopharm Company Information

Table 63. Sinopharm Introduction and Business Overview

Table 64. Sinopharm Cefuroxime Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 65. Sinopharm Cefuroxime Sodium Product Offerings

Table 66. Sinopharm Recent Development

Table 67. Yongning Pharma Company Information

Table 68. Yongning Pharma Introduction and Business Overview

Table 69. Yongning Pharma Cefuroxime Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 70. Yongning Pharma Cefuroxime Sodium Product Offerings

Table 71. Yongning Pharma Recent Development

Table 72. Titan Pharmaceutical Company Information

Table 73. Titan Pharmaceutical Introduction and Business Overview

Table 74. Titan Pharmaceutical Cefuroxime Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 75. Titan Pharmaceutical Cefuroxime Sodium Product Offerings

Table 76. Titan Pharmaceutical Recent Development

Table 77. ACS Dobfar Company Information

Table 78. ACS Dobfar Introduction and Business Overview

Table 79. ACS Dobfar Cefuroxime Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 80. ACS Dobfar Cefuroxime Sodium Product Offerings

Table 81. ACS Dobfar Recent Development

Table 82. Guobang Pharma Company Information

Table 83. Guobang Pharma Introduction and Business Overview

Table 84. Guobang Pharma Cefuroxime Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 85. Guobang Pharma Cefuroxime Sodium Product Offerings

Table 86. Guobang Pharma Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Cefuroxime Sodium Downstream Customers

Table 90. Cefuroxime Sodium Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Cefuroxime Sodium Product Picture

Figure 2. Global Cefuroxime Sodium Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Cefuroxime Sodium Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Cefuroxime Sodium Sales Volume (2020-2031) & (MT)

Figure 5. Global Cefuroxime Sodium Sales Price (2020-2031) & (USD/Kg)

Figure 6. Cefuroxime Sodium Report Years Considered

Figure 7. Global Cefuroxime Sodium Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Cefuroxime Sodium Players Sales Volume Ranking (2024) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cefuroxime Sodium Revenue in 2024

Figure 10. Cefuroxime Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. ≥ 96.0% Picture

Figure 12. ＜ 96.0% Picture

Figure 13. Global Cefuroxime Sodium Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Cefuroxime Sodium Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Cefuroxime Sodium Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)

Figure 16. Global Cefuroxime Sodium Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Cefuroxime Sodium Price by Type (2020-2031) & (USD/Kg)

Figure 18. Product Picture of Respiratory Infections

Figure 19. Product Picture of ENT Infections

Figure 20. Product Picture of Urinary Tract Infection

Figure 21. Product Picture of Meningitis

Figure 22. Product Picture of Other

Figure 23. Global Cefuroxime Sodium Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 24. Global Cefuroxime Sodium Sales Value Market Share by Application, 2024 & 2031

Figure 25. Global Cefuroxime Sodium Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)

Figure 26. Global Cefuroxime Sodium Sales Volume Market Share by Application, 2024 & 2031

Figure 27. Global Cefuroxime Sodium Price by Application (2020-2031) & (USD/Kg)

Figure 28. North America Cefuroxime Sodium Sales Value (2020-2031) & (US$ Million)

Figure 29. North America Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

Figure 30. Europe Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

Figure 32. Asia Pacific Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Cefuroxime Sodium Sales Value by Region (%), 2024 VS 2031

Figure 34. South America Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 35. South America Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

Figure 36. Middle East & Africa Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 37. Middle East & Africa Cefuroxime Sodium Sales Value by Country (%), 2024 VS 2031

Figure 38. Key Countries/Regions Cefuroxime Sodium Sales Value (%), (2020-2031)

Figure 39. Key Countries/Regions Cefuroxime Sodium Sales Volume (%), (2020-2031)

Figure 40. United States Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 41. United States Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 42. United States Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 43. Europe Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 44. Europe Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 45. Europe Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 46. China Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 47. China Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 48. China Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 49. Japan Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 50. Japan Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 51. Japan Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 52. South Korea Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 53. South Korea Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 54. South Korea Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 55. Southeast Asia Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 56. Southeast Asia Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 57. Southeast Asia Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 58. India Cefuroxime Sodium Sales Value, (2020-2031) & (US$ Million)

Figure 59. India Cefuroxime Sodium Sales Value by Type (%), 2024 VS 2031

Figure 60. India Cefuroxime Sodium Sales Value by Application (%), 2024 VS 2031

Figure 61. Cefuroxime Sodium Industrial Chain

Figure 62. Cefuroxime Sodium Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Cefuroxime Sodium market? zhanKai

The top companies in the global Cefuroxime Sodium market are NecLife、Sinopharm、Yongning Pharma.

Related Reports

Cefuroxime Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cefuroxime Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
Global Cefuroxime Sodium Market Research Report 2026
The global Cefuroxime Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 127
USD 2900.00
(Single User License)
Global Cefuroxime Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cefuroxime Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 147
USD 4900.00
(Single User License)
Global Cefuroxime Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cefuroxime Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 80
USD 4250.00
(Single User License)
Global Cefuroxime Sodium Market Research Report 2025
The global market for Cefuroxime Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 94
USD 2900.00
(Single User License)
Cefuroxime Sodium - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Cefuroxime Sodium was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 102
USD 3950.00
(Single User License)
Global Cefuroxime Sodium Market Research Report 2024
The global Cefuroxime Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 93
USD 2900.00
(Single User License)

Cefuroxime Sodium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cefuroxime Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 129
USD 3950.00 (Single User License)
Global Cefuroxime Sodium Market Research Report 2026
The global Cefuroxime Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 127
USD 2900.00 (Single User License)
Global Cefuroxime Sodium Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cefuroxime Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 147
USD 4900.00 (Single User License)
Global Cefuroxime Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cefuroxime Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 80
USD 4250.00 (Single User License)
Global Cefuroxime Sodium Market Research Report 2025
The global market for Cefuroxime Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 94
USD 2900.00 (Single User License)
Cefuroxime Sodium - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Cefuroxime Sodium was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 102
USD 3950.00 (Single User License)
Global Cefuroxime Sodium Market Research Report 2024
The global Cefuroxime Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 93
USD 2900.00 (Single User License)